biolargo ld micro deck 12 3-2014 (final)
TRANSCRIPT
BioLargo, Inc.OTCQX: BLGO
Corporate Presentation September 2014Fall 2014
Forward Looking StatementsThe statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2013.
OTCQB: BLGO
2
About BioLargowe make life better
BioLargo, Inc.• platform technology company• leveraging iodine chemistry • solving the world’s most
challenging issues in• water decontamination• disinfection• wound care• odor elimination• moisture control
Consumer products
Water disinfection
Water decontamination
Wound care & disinfection
3
BioLargo AOS Water Filter“Unprecedented Results”
• 100x more effective• 1/20th the cost• >10x faster
• Independently Tested and Verified by Acclaimed Researchers at Univ. of Alberta
4
The Science
–Not Your Grandmother’s Iodine
–Extremely high OXIDATION
–Forget what you knew before
5
Salmonella Case Study –100,000 cells = infection–94 million cases /yr –155,000 Deaths–USDA Reports cost at ≈ $2.65B/yr
6
Extreme Oxidation Potential
• Chlorine Dioxide:• 100,000 cells• 60 min. for total kill
• BioLargo AOS Filter:•10,000,000 cells•2 min. for total kill
VS.
*UP TO 100,000 Salmonella cells can be found in one mouse dropping
Commercial Pilot
Iodine + Electrolysis + Filter Media7
8
(+) (-)
H20
H20
I2
Iodine + Electrolysis + Filter Media
AOS Filter: Value Proposition
Achieves unprecedented levels of disinfection and rapidly dismantles & removes soluble organic contaminants, including toxic contaminants missed by other filterso “Hot” advanced oxidation potentialo Self regenerating coated filtration
media with no caustic chemicalso Continuous flow with no backwash
downtimeo Extremely low powero High speed, high capacity with
modular design
AOS Filter- Converts a Filter into a Reactor
(+) (-)
H20
H20
I2AOS
9
10
Delivering ProvenCompetitive Advantage
Characteristics BioLargo Competing Ozone Technology
Time o Instantaneous reduction o 5 to 6 hours
Process o Continual free-flowing o Batch processing
Energy o Very low power consumption o Significant power required
Footprint o Small o Large space needed
Results = Fraction of the cost = Not commercially cost effective
AOS rapidly dismantles difficult soluble contaminants and disinfects
< 1/20th the cost of the nearest competition
11
Impact on Every Segment of the $360B Water Industry
Athabasca Oil Sands
Food Processing Production
Process & Produced Water
Fracking Remediation Ultra-pure Cooling
Municipal Waste Water Ballast Home Applications Third World
12
Water: AOS Filter
• Where to Focus: – fastest to market– where we experience pull
• Broad effectiveness against long list of contaminant
• Global licensing model
13
Well-Positioned in CanadaCharter Member of stake holder cooperative established to resolve tailings pond water
NSERC Research Chair at the University of Alberta (Dept. of Engineering)
o BioLargo is charter member (2011)
o Joined by top Canadian oil
companies, Canadian agencies and
leading researchers from the field
o Backed in large part by the
Canadian federal government
NSERC = Natural Sciences & Engineering Research Council of Canadawww.nserc-crsng.gc.ca
o Syncrude Canada, Ltd.o Suncor Energy, Inc.o Shell Canada, Ltd.o Canadian Natural Resources, Ltd.o Total E&P Canada Ltd.o EPCOR Water Services, Inc.o BioLargo, Inc.o Alberta Innovateso Alberta Environment
14
Secured IP RightsSetting the foundation for sales & licensing with the pilot terms:
BioLargo
Owns 100%
resulting IP
95%of
revenue
$1.6M CND
to fundover 4 years
Univ. of Alberta
5%Royalty
>$3.5M CND
Grant Aid
15
Assets built to license: Advanced Wound Care
• Pathway to Success is clear for $1B+ opportunity– 510k + $500k + licensing – $5MM + per year in licensing revenues out of the gate– ≈95% of the Work is Complete– currently negotiating with three global companies
• Exceptional- Proven Leadership Team• Liquids, Hydrogels & Dressings• High Profit Margins
16
Assets built to license: Consumer Products
• Over 30 Fully Developed Products – Demo Sells Products Instantly– Multiple Product of the Year Awards– Best-In-Class (Validated @ Veritas)
• Target Licensing Revenues – $250K to $1MM Annually PER Product
• Strategic Licensing Deals in works Now- Including; #1 Brand in the USA to launch into largest retailers in industry
17
Leadership TeamExecutive
Joined BLGO
Experience
Dennis CalvertChairman, President & CEO
2003 o 20 years as an entrepreneur, investor and consultant
Kenneth CodeInventor & CTO Founder o Chemist, Entrepreneur and Creator of BioLargo’s technology
o Developing the technology since 1997
Richard Smith, PhDPresident, BioLargo Water 2014 o PhD in Viral Immunopathology &
o 10+ years working with biotech companies in Alberta, including ChemBioMed and VirRexx
Vikram Rao, PhDSr. Advisor 2010 o 30 years in petroleum industry, former CTO & EVP at Halliburton; ED of Research Triangle
Energy Consortium, author of 40+ publications and holder of 24+ patents
Harry DeLongeSr. Advisor 2011 o 40+ years as Pepsi-Cola’s Int’l V.P. of Technical Services & V.P. of Manufacturing Technology
o Water Expert
Joseph ProvenzanoV.P. of Operations 2003 o 15 years in mergers and acquisitions, operations and marketing
Robert SzolomayerDir. of Corp. Development 2004 o 35 years in Real Estate; five years managing $1B Northrop Grumman project
Steve HarrisonDir. of Int’l Ventures 2003 o 25 years of experience as an Entrepreneur and Business Founder beyond U.S. soil
Tim R. JohnsonDir. of Medical Products 2012 o 25 years medical device industry, successful entrepreneur founded, developed and sold
medical products company to Smith and Nephew
Tanya Rhodes PhDCTO Clyra Medical 2013
o Chemistry PhDo 25 years advanced wound care industry, Sr. VP, Regulatory & Innovation Smith and
Nephew
AJ Sexton VDir. of Bus. Development 2014 o 25 years Investment Banking, License FINRA Series 7, 63 and 79 licenses
18
The Plan
Unlock the value to accelerate success
Broaden shareholder base Execute the near term commercial
opportunities Partner with leaders Monetize the assets Up list & build a market
19
Company Contacts:Dennis Calvert - President & CEO 949.643.9540
AJ Sexton - Director of Bus Dev. - 949.945.8450
[email protected] or [email protected]
www.biolargo.com